Viewing data from:

NEFAZODONE HYDROCHLORIDE

ANDA

NEFAZODONE HYDROCHLORIDE | A076073 | WATSON LABORATORIES INC

4 strengths0 unique patents0 unique exclusivities

API Supply Chain1 active DMF1 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

TAPI NL BVNEFAZODONE HYDROCHLORIDE USP

DMF 142791999

SIGNA SA DE CVInactiveNEFAZODONE HYDROCHLORIDE

DMF 163872003

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#002 — 100MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Sep 16, 2003

No patent or exclusivity listings for this strength.

#003 — 150MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 16, 2003

#004 — 200MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 16, 2003

#005 — 250MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 16, 2003